SURFACE ONCOLOGY, INC.: cashflow_investing
| Value | {"amount": -99252000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-12-31 |
| Status | current |
| Entity | SURFACE ONCOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:34:37.780693+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2d700509-39a8-413b-8ee1-532e85cd9b8e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001718108-22-000006Retrieved: 2026-08-19T17:34:37.780693+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001718108/cashflow-investing/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2d700509-39a8-413b-8ee1-532e85cd9b8e
History
- no predecessors — first report